Antiulcerogenic Activity And Toxicity Of Bauhinia Holophylla Hydroalcoholic Extract. by Rozza, A L et al.
Research Article
Antiulcerogenic Activity and Toxicity of
Bauhinia holophylla Hydroalcoholic Extract
A. L. Rozza,1 D. A. S. Cesar,1 L. G. Pieroni,2 L. L. Saldanha,2 A. L. Dokkedal,3 F. M. De-Faria,4
A. R. M. Souza-Brito,4 W. Vilegas,5 R. K. Takahira,6 and C. H. Pellizzon1
1Laboratory of Experimentation of Natural Products, Morphology Department, Institute of Biosciences,
Universidade Estadual Paulista (UNESP), 18618-970 Botucatu, SP, Brazil
2Botany Department, Institute of Biosciences, Universidade Estadual Paulista (UNESP), 18618-970 Botucatu, SP, Brazil
3Biological Science Department, Science Faculty, Universidade Estadual Paulista (UNESP), 17033-360 Bauru, SP, Brazil
4Department of Structural and Functional Biology, Institute of Biology, University of Campinas (Unicamp),
13083-862 Campinas, SP, Brazil
5Experimental Campus of the Paulista Coast, Universidade Estadual Paulista (UNESP), 11330-900 Sa˜o Vicente, SP, Brazil
6Clinics Veterinary Department, School of Veterinary Medicine and Animal Science, Universidade Estadual Paulista (UNESP),
18618-970 Botucatu, SP, Brazil
Correspondence should be addressed to C. H. Pellizzon; claudia@ibb.unesp.br
Received 27 November 2014; Revised 12 February 2015; Accepted 10 March 2015
Academic Editor: Lay Kek Teh
Copyright © 2015 A. L. Rozza et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Several species of Bauhinia are used in traditional medicine for the treatment of gastrointestinal diseases, diabetes, and
inflammation, among other conditions. The aim of this study was to investigate the antiulcer effect of a hydroalcoholic extract
from the leaves of B. holophylla. The chemical profile of the extract was determined by HPLC-PAD-ESI-IT-MS. A dose-effect
relation was constructed using the ethanol-induced gastric ulcer model in male Wistar rats. Histological analyses and studies of
antioxidant and anti-inflammatory activities were performed in stomach samples. The involvement of SH compounds, NO, K+ATP
channels, and 𝛼
2
-adrenergic receptors in the gastroprotective effect was evaluated. A toxicity study was performed with a single oral
dose of 5000mg/kg. The extract was composed mainly of cyanoglucoside and flavonol-O-glycosides derivatives of quercetin and
myricetin. SH compounds, NO release, K+ATP channel activation, and presynaptic 𝛼2-adrenergic receptor stimulation each proved
to be involved in the antiulcer effect. The levels of GSH and activity of GR and GPx were increased, and the levels of TNF-𝛼, IL-6
and IL-10 were modulated. There was an antidiarrheal effect and there were no signs of toxicity. B. holophylla presents antiulcer
activity mainly by decreasing oxidative stress and attenuating the inflammatory response, without inducing side effects.
1. Introduction
Thepathogenesis of gastric ulcer is commonly associatedwith
alterations of physiologic parameters, such as the excessive
secretion of gastric acid, disruption of the mucus barrier,
formation of reactive oxygen species, lipid peroxidation, and
the release of inflammatory mediators, among other factors
[1]. Despite the clinical and commercial success of the current
treatments for gastric ulcer, there are important clinical needs
that remain unmet. Faster and better symptom control, more
rapid healing, lack of tolerance, and increased time in the
plasma to avoid ineffectiveness, especially at night, are some
examples of the persistent goals [2, 3].
The search for a new therapy has driven research to
focus on medicinal plants and natural products. In Brazil,
several species of Bauhinia are known as “pata de vaca”
and have been widely used in the treatment of several
conditions, such as infections, pain, diabetes, and gastric
ulcer [4]. Several ethnopharmacological studies have been
carried out on different species of Bauhinia. The methanolic
and chloroformic extracts of Bauhinia thonningii [5] and the
chloroformic [6], methanolic [7], and aqueous [8] extracts
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of Bauhinia purpurea previously presented antiulcer effects
in rats. Despite the traditional use of the genus Bauhinia,
including B. holophylla, to the best of our knowledge, there
are no studies regarding in vivo effects of B. holophylla. The
present study aimed to investigate the antiulcerogenic activity
of the hydroalcoholic extract of B. holophylla leaves and the
mechanisms underlying its gastroprotective effect.
2. Material and Methods
2.1. Plant Material and Extraction. Samples of B. holophylla
leaves were collected in November 2010 at the Botanical
Garden of Bauru (22∘20󸀠30󸀠󸀠S and 49∘00󸀠30󸀠󸀠W), SP, Brazil.
Voucher specimens were prepared and identified by Dr.
Aˆngela Maria Studart da Fonseca Vaz and stored at the
Herbarium of the Botanical Garden of Rio de Janeiro (Rio
de Janeiro/RJ, Brazil) under code number RB 507.043, RB
507.045, RB 507.046, RB 507.47, and RB 507.048. Fresh leaves
were dried at 40∘C for 48 h. Separated powdered leaves were
extracted with EtOH/H
2
O (7 : 3) by percolation at room
temperature. The filtrate was concentrated to dryness under
reduced pressure at 40∘C furnishing the hydroalcoholic
extract yielding 29.5% of the dry weight.
2.2. Chemical Profile of the 70% EtOH Extract by HPLC-
PAD-ESI-IT-MS. The chromatographic profile of the extract
of B. holophylla was determined on an Accela High Speed
LC (Thermo Scientific, San Jose, CA, USA) equipped with
a Phenomenex Luna C
18
(250 × 4.6mm i.d.; 5 𝜇m) column
and a 4 × 3mm i.d. column guard (Phenomenex), with PAD,
and coupled to an Accela (Thermo Scientific) LCQ Fleet with
Ion Trap (IT) 3D and ionization by electrospray (ESI). The
mobile phase was ultrapure water (eluent A) and methanol
(eluent B), both containing 0.1% formic acid. A gradient
of 25–100% B over 70min was applied, with the following
conditions: injection volume, 10.0 𝜇L; column temperature,
25∘C; and flow ratio, 0.8mL⋅min−1. UV-vis spectra were
recorded between 200 and 600 nm, and the chromatographic
profiles were registered at 360 nm. The identification of
compounds was carried out by comparison of retention time,
maximal UV-vis wavelength, and mass spectral data with
those of standards and the literature [9]. The effluent from
the HPLC was directed into the ESI probe. The 70% EtOH
extract was dissolved in MeOH-H
2
O (8 : 2) and analyzed at a
final concentration of 100𝜇g⋅mL−1.
2.3. Animals. Male Wistar rats (200–250 g) from the Central
Animal House of UNESP were fed a certified diet with free
access to tap water under standard light-dark cycles (12/12 h),
humidity (60 ± 1%), and temperature (21 ± 2∘C). All rats
were fasted for at least 16 hours prior to each experiment
because the treatments were orally administered. After each
experiment, the rats were euthanized in a presaturated CO
2
chamber. All efforts were made to minimize the suffering of
the rats. All experimental protocols followed the recommen-
dations of the Canadian Council on Animal Care [10] and
were approved by the UNESP Institutional Animal Care and
Use Committee (permit number 342-CEUA).
2.4. Ethanol-Induced Gastric Ulcers: Determination of Dose.
Male Wistar rats were distributed into five groups (𝑛 = 7)
and then orally dosedwith vehicle (10mL/kg), carbenoxolone
(100mg/kg), or B. holophylla (50, 100, or 150mg/kg). After 1
hour, the animals received an oral dose of 1mL of absolute
ethanol. One hour after ethanol treatment, the rats were
euthanized, and their stomachs were removed [11]. The
stomachs were then opened along the greater curvature and
washed. The stomachs were scanned, and the ulcer area
(mm2) was measured using the AVSoft BioView software.
After the statistical analysis of the data, the lower effective
dose of the 3 doses tested was adopted for all other assays.
2.4.1. Histological Analysis. After scanning, samples from the
stomach of each rat were fixed in ALFAC solution (85% alco-
hol 80, 10% formalin, and 5% acetic acid) and processed in a
paraffin tissue processing machine. Sections of the stomach
were cut to a thickness of 5 𝜇m and stained with hematoxylin
and eosin (HE) or periodic acid-Schiff (PAS) for histological
evaluation.
2.4.2. Preparation of Samples for Biochemical Assays. Imme-
diately after the animals were euthanized, the mucosa of each
stomach was scraped using two glass slides, homogenized
in a phosphate buffer (0.1M, pH 7.4), and frozen at −80∘C
until biochemical analysis. The protein concentration of
the samples was determined by the method described by
Bradford [12].
(1) Determination of Total Glutathione (GSH) Levels.TheGSH
levels in gastric tissue were determined by Ellman’s reaction
using 5󸀠5󸀠-dithio-bis-2-nitrobenzoic acid (DTNB) [13]. The
intensity of the yellow color was read using spectrophotome-
try at 412 nm.
(2) Glutathione Peroxidase (GSH-Px) Activity. The GSH-
Px activity was measured by combining 10mM of reduced
glutathione, 4mM of NADPH, and 1U enzymatic activity of
GSH-Px; the decrease in absorbancewas induced by 0.25mM
H
2
O
2
and monitored every minute for 10 minutes at 365 nm
[14].
(3) Glutathione Reductase (GR) Activity. The GR activity
was measured by monitoring the decrease in absorbance
of NADPH induced by oxidized glutathione in phosphate
buffer, pH 7.8 at 340 nm. The absorbance was read every
minute for 10 minutes [15].
(4) Superoxide Dismutase Activity (SOD). The SOD activity
was analyzed by the reduction of nitroblue tetrazolium
using a hypoxanthine-xanthine oxidase system (superoxide
generation). The absorbance was read every minute for 10
minutes at 560 nm [16].
(5) Myeloperoxidase (MPO) Activity. TheMPO activity in the
gastricmucosa wasmeasured to evaluate the accumulation of
neutrophils. The samples were centrifuged at 3,000×g for 15
minutes at 4∘C. Aliquots of the supernatant were then mixed
with a reaction buffer of 50mMphosphate containing 0.005%
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H
2
O
2
and 1.25mg/mL O-dianisidine dihydrochloride (pH
6.8) and measured at 460 nm [17].
2.4.3. Measurement of the Gastric Mucosal Levels of TNF-𝛼,
IL-6, and IL-10. The tissue homogenate was centrifuged, and
the cytokines were detected in the supernatant using com-
mercial enzyme-linked immunosorbent assay (ELISA) kits
for tumor necrosis factor 𝛼 (TNF-𝛼) and interleukins 6 (IL-6)
and 10 (IL-10) (BioLegend, San Diego, CA, USA).
2.5. Involvement of Sulfhydryl (SH) Compounds or Nitric
Oxide (NO) in Gastroprotection. The rats were distributed
into six groups (𝑛 = 7). Two groups of rats were intraperi-
toneally treated with NEM (N-ethylmaleimide 5mg/kg, an
SH compound blocker), two groups were treated with L-
NAME (N-nitro-L-arginine methyl ester 70mg/kg, an NO
synthase inhibitor), and two groups were treated with vehicle
(10mL/kg). One hour later, the vehicle or B. holophylla
150mg/kg was orally administered to two groups each. After
60 minutes, all groups were orally treated with 1mL of
absolute ethanol for gastric ulcer induction [18]. Animals
were killed one hour after the ethanol administration, and the
stomachs were removed, opened along the greater curvature,
and scanned; the ulcer area (mm2) was determined with the
aid of the software AVSoft BioView.
2.6. Involvement of K+ATP Channels or Presynaptic 𝛼2-
Receptors in Gastroprotection. The rats were distributed
into six groups (𝑛 = 7). Two groups of rats were
intraperitoneally treated with glibenclamide (5mg/kg, a
K+ATP channels blocker), two groups were intraperitoneally
treated with yohimbine (3mg/kg, a 𝛼
2
-receptors antagonist),
and two groups were intraperitoneally treated with vehicle
(10mL/kg). One hour later, the vehicle or B. holophylla
150mg/kg was orally administered to two groups each. After
60 minutes, all groups were orally treated with 1mL of
absolute ethanol for gastric ulcer induction [19]. Animals
were killed one hour after the ethanol administration, and the
stomachs were removed, opened along the greater curvature,
and scanned; the ulcer area (mm2) was determined using of
the software AVSoft BioView.
2.7. Effect of B. holophylla on Castor Oil-Induced Diar-
rhea. Three groups of rats were orally treated with vehicle
(10mL/kg), loperamide hydrochloride (3mg/kg), or B. holo-
phylla (150mg/kg). After 30 minutes, each rat received 1mL
of castor oil orally. Immediately after ingesting the castor oil,
each rat was kept in an individual cage, the floor of which
was lined with blotting paper, and the rats were observed
for 5 hours. The following parameters were then observed:
onset of diarrhea, number of solid, semisolid, and watery
feces and total frequency of fecal outputs. Each rat received
an evacuation index (EI) expressed according to the formula:
EI = 1 × (number of solid stool) + 2 × (number of semisolid
stool) + 3 × (number of watery stool) [20].
2.8. Effect of B. holophylla on Gastrointestinal Motility. Rats
were orally treated with vehicle (10mL/kg), loperamide
hydrochloride (4mg/kg), or B. holophylla (150mg/kg). After
20 minutes, each rat orally received 1mL of charcoal meal
(10% charcoal suspension in 5% aqueous gum arabic). After
30 minutes, rats were euthanized, and the stomach and small
intestine were removed. The distance between the charcoal
meal and the pylorus was measured and correlated with the
distance from the pylorus to the caecum [21].
2.9. Acute Toxicity. Male rats (𝑛 = 10) orally received vehicle
or a single acute dose of B. holophylla (5000mg/kg) after 12
hours of fasting. Possible signs and symptoms associated with
toxicity were observed at 0, 30, 60, 120, 180, and 240 minutes
after the administration and then twice daily for the next
14 days. Body weights were noted daily. At the end of the
period, the rats were euthanized, and the kidneys and liver
were removed, weighed, and evaluated. Biochemical analyses
were performed on the rats’ serum to quantify AST (aspartate
aminotransferase), ALT (alanine aminotransferase), 𝛾-GT
(gamma glutamyltransferase), and alkaline phosphatase to
evaluate liver damage and creatinine and urea to evaluate
kidney damage using the automated biochemical analyzer
SBA-200, CELM, Brazil.
2.10. Statistical Analysis. We analyzed parametric data using
an unpaired 𝑡-test or a one-way analysis of variance
(ANOVA) followed by Dunnett’s test and compared the
results to the vehicle group or Tukey’s test. We performed the
analyses usingGraphPad InStat or Prism software (GraphPad
Software, La Jolla, CA, USA), and the results are presented
as the mean ± standard error of the mean (SEM). A value of
𝑃 < 0.05 was considered significant.
3. Results
3.1. Chemical Fingerprinting. The chemical fingerprinting of
the 70% EtOH leaf extract of B. holophylla by HPLC-PAD-
ESI-IT-MS revealed the presence of flavonol-O-glycosides
derivatives of quercetin and myricetin as main constituents
(Figure 1).
3.2. Ethanol-Induced Gastric Ulcers
3.2.1. Gastric Ulcer Area. The vehicle group presented an
average ulcer area of 458.15 ± 83.52mm2, characterized by
hemorrhagic bands (Figure 2). The reference drug carbenox-
olone provided 88% gastroprotection (𝑃 < 0.01). Among
the groups treated with B. holophylla (50, 100, or 150mg/kg),
only the highest dose exhibited a gastroprotective effect (75%
gastroprotection, 𝑃 < 0.01), with an average ulcer area of
114.55±12.40mm2 (Figure 3). A dose of 150mg/kg was used
for all subsequent experiments.
3.2.2. Histological Analysis. The groups of rats treated with
carbenoxolone or B. holophylla 150mg/kg showed a decrease
in the occurrence of characteristics typical of ethanol-
induced lesions (hemorrhagic lesions, eosinophilic infiltra-
tion, desquamation, and glandular damage).ThePAS staining
provided evidence of the mucus polysaccharides inside the
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Figure 1: HPLC-PAD analytical chromatogram of 70% EtOH leaf extract of Bauhinia holophylla. Experimental conditions: eluents A (H
2
O
+ 0.1% formic acid) and B (MeOH + 0.1% formic acid). Gradient system: 25–100% B over 70min. Column: Phenomenex Luna C18 (250 ×
4.6mm i.d., 5𝜇m). Flow rate: 0.8mL⋅min−1 and 𝜆 = 360 nm. Injected volume: 10𝜇L. Identified compounds: 1, myricetin-O-deoxyhexoside,
2, quercetin-O-hexoside, 3, quercetin-O-pentoside, 4, quercetin-O-deoxyhexoside, and 5, isorhamnetin.
(a) (b) (c)
Figure 2: Macroscopic appearance of rat stomachs with ethanol-induced gastric ulcers after treatment with (a) vehicle, (b) carbenoxolone
(100mg/kg), or (c) Bauhinia holophylla (150mg/kg). Arrows indicate ulcer formation.
gastric pits of the B. holophylla-treated rats. The histological
properties of the ulcers are displayed in Figure 4.
3.2.3. Assays of Antioxidant Activity. B. holophylla increased
the level of GSH (𝑃 < 0.05) and the activities of the enzymes
GSH-Px (𝑃 < 0.05) and GR (𝑃 < 0.01). There was a light
decrease in the SOD activity; however, this result was not
statistically significant. The results of antioxidant activity are
presented in Table 1.
3.2.4. Myeloperoxidase (MPO) Activity. The B. holophylla-
treated rats presented a significant decrease (𝑃 < 0.05) in the
activity of the MPO enzyme in the stomach compared to the
vehicle-treated group (Table 1).
Table 1: Effect of Bauhinia holophylla (150mg/kg) on the levels of
MPO (myeloperoxidase), GSH (glutathione), GSH-Px (glutathione
peroxidase), GR (glutathione reductase), SOD (superoxide dismu-
tase), and MPO (myeloperoxidase) in rat stomachs after ethanol-
induced gastric ulcers.
Vehicle Carbenoxolone Bauhinia holophylla
GSH 25.88 ± 2.67 54.48 ± 6.78∗∗ 42.82 ± 1.69∗
GSH-Px 96.07 ± 7.21 108.30 ± 14.67 136.80 ± 8.42∗
GR 31.51 ± 1.93 40.95 ± 3.12∗ 42.50 ± 1.00∗∗
SOD 3.33 ± 0.50 1.65 ± 0.38∗ 2.60 ± 0.48
MPO 0.07 ± 0.00 0.04 ± 0.00∗∗ 0.05 ± 0.00∗
GSH level is expressed in nmol/mg of protein; GPx and GR are expressed in
nmol/min/mg of protein; SOD and MPO are expressed in U/mg of protein.
The results are reported as the mean ± SEM. ANOVA followed by Dunnett’s
test, ∗𝑃 < 0.05, ∗∗𝑃 < 0.01.
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Figure 3: Gastric ulcer area (mm2) of rat stomachs with ethanol-induced gastric ulcers after treatment with vehicle, carbenoxolone
(100mg/kg), or Bauhinia holophylla (50, 100, or 150mg/kg). The results are reported as the mean ± SEM. ANOVA followed by Dunnett’s
test, 𝑃 < 0.05.
(a)
+
(b) (c)
#
(d) (e)
∗
(f)
Figure 4: Rat stomachs with ethanol-induced gastric ulcers after treatment with (a, d) vehicle, (b, e) carbenoxolone (100mg/kg), or (c, f)
Bauhinia holophylla (150mg/kg). In the HE staining (a, b, c), the gastric mucosa is more preserved in (b) and (c), besides desquamation,
indicated by +. Arrow indicates ulcer formation. In the PAS staining (d, e, f), purple stained area (∗) indicates the mucus secretion in the
gastric glands and # indicates glandular damage.
3.2.5. Assays of Anti-Inflammatory Activity. B. holophylla
showed anti-inflammatory activity in the gastric mucosa, as
the treatment decreased (𝑃 < 0.001) the production of the
proinflammatory cytokines TNF-𝛼 and IL-6 and increased
the level of the anti-inflammatory cytokine IL-10 (𝑃 < 0.05)
(Table 2).
3.3. Involvement of SH Compounds or NO in Gastroprotec-
tion. In rats that were pretreated with NEM 5mg/kg or L-
NAME 70mg/kg, the gastroprotective effect of B. holophylla
(𝑃 < 0.01) (150mg/kg) was reversed, demonstrating the
importance of SH compounds and NO production to the
gastroprotective effect (Table 3).
3.4. Involvement of K+ATP Channels or Presynaptic 𝛼2-
Receptors in Gastroprotection. The administration of gliben-
clamide 5mg/kg (K+ATP channels blocker) and yohimbine
3mg/kg (𝛼
2
presynaptic receptor antagonist) reversed the
gastroprotective effect of B. holophylla (𝑃 < 0.01), indicating
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Table 2: Effect of Bauhinia holophylla (150mg/kg) on the levels of TNF-𝛼, IL-6, and IL-10 cytokines in rat stomachs after ethanol-induced
gastric ulcers.
Vehicle Carbenoxolone Bauhinia holophylla
TNF-𝛼 2076.00 ± 122.80 1307.00 ± 283.30∗ 11.69 ± 5.04∗∗∗
IL-6 1273.00 ± 57.56 854.60 ± 169.30∗ 80.29 ± 23.99∗∗∗
IL-10 1923.10 ± 98.15 4607.00 ± 502.50∗∗∗ 3317.52 ± 399.20∗
The results are expressed as pg/mg of protein and reported as the mean ± SEM. ANOVA followed by Dunnett’s test, ∗𝑃 < 0.05, and ∗∗∗𝑃 < 0.001.
Table 3: Effect of Bauhinia holophylla (150mg/kg) on ethanol-induced gastric ulcer area (mm2) in rats that were pretreated with L-NAME
(NO synthase inhibitor) or NEM (SH compound blocker).
Pretreatment (i.p.) Treatment (p.o.) Ulcer area (mm2) Gastroprotection (%)
Vehicle Vehicle 643.71 ± 113.76 —
B. holophylla 220.42 ± 68.67∗∗ 65.75
L-NAME 70mg/kg Vehicle 617.74 ± 116.73 —
B. holophylla 419.24 ± 131.32 32.13
NEM 5mg/kg Vehicle 460.38 ± 136.06 —
B. holophylla 608.93 ± 215.24 —
The results are reported as the mean ± SEM. Unpaired 𝑡-test, ∗∗𝑃 < 0.01.
Table 4: Effect ofBauhinia holophylla (150mg/kg) on ethanol-induced gastric ulcer area (mm2) in rats thatwere pretreatedwith glibenclamide
(K+ATP channels blocker) or yohimbine (presynaptic 𝛼2 adrenoceptors antagonist).
Pretreatment (i.p.) Treatment (p.o.) Ulcer area (mm2) Gastroprotection (%)
Vehicle Vehicle 511.51 ± 103.42 —
B. holophylla 159.52 ± 36.66∗∗ 68.81
Glibenclamide 5mg/kg Vehicle 501.18 ± 258.95 —
B. holophylla 306.47 ± 83.28 38.85
Yohimbine 3mg/kg Vehicle 829.40 ± 264.30 —
B. holophylla 422.62 ± 174.13 49.04
The results are reported as the mean ± SEM. Unpaired 𝑡-test, ∗∗𝑃 < 0.01.
Table 5: Evacuation index and intestinal motility (cm2) after oral treatment with vehicle, loperamide hydrochloride, or Bauhinia holophylla
(150mg/kg).
Vehicle Loperamide B. holophylla
Evacuation index 13.33 ± 0.21 7.16 ± 0.16∗∗ 9.50 ± 0.22∗∗
% of evacuation inhibition — 46.28 28.73
Intestinal motility 40.05 ± 2.94 17.66 ± 2.33∗ 40.24 ± 3.91
% of motility inhibition — 55.90 —
The results are reported as the mean ± SEM. ANOVA followed by Dunnett’s test, ∗𝑃 < 0.05 or ∗∗𝑃 < 0.01.
that both pathways are important to the B. holophylla gastro-
protection (Table 4).
3.5. Effect of B. holophylla on Castor Oil-Induced Diarrhea and
Gastrointestinal Motility. B. holophylla reduced evacuation
by 28.73% compared to the vehicle group (𝑃 < 0.01),
indicating an antidiarrheal activity. However, B. holophylla
treatment showed no interference in the time of transit of
the fecal content treated animals compared to vehicle group
(Table 5).
3.6. Acute Toxicity. There were no signs of toxicity during the
period that the rats were observed (14 days).The body weight
of the rats progressed normally, and there were no alterations
in the biochemical parameters analyzed in the rats’ serum,
indicating that the dose of 5000mg/kg did not induce renal or
hepatic toxicity with regard to any of the parameters analyzed
(Table 6).
4. Discussion
This study aimed to investigate the activity of the hydroalco-
holic extract of Bauhinia holophylla toward ethanol-induced
gastric ulcers in rats. Regarding the chemical analysis, deriva-
tives of quercetin andmyricetin were revealed in fingerprints
ofB. holophylla extract as themain constituents in accordance
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Table 6:Effect of orally administeredBauhinia holophylla (5000mg/
kg) on rats’ body weight and serum biochemical parameters.
Vehicle Bauhinia holophylla
Initial body weight (day 0) 196.70 ± 5.31 203.08 ± 4.73
Final body weight (day 14) 290.60 ± 8.29 298.45 ± 8.19
AST 82.00 ± 4.71 77.71 ± 2.22
ALT 43.42 ± 2.17 47.00 ± 2.70
Gamma-GT 6.45 ± 0.58 5.65 ± 0.90
Alkaline phosphatase 271.57 ± 21.51 252.57 ± 26.51
Creatinine 0.30 ± 0.02 0.28 ± 0.02
Urea 51.71 ± 2.25 50.57 ± 1.11
Body weights are expressed in g. AST, ALT, 𝛾-GT, and alkaline phosphatase
are expressed in U/L; creatinine and urea are expressed inmg/dL.The results
are reported as the mean ± SEM. Unpaired 𝑡-test.
with a study of another species of Bauhinia, B. forficata [9]. In
this study, we found that B. holophylla only presented a gas-
troprotective effect in the highest dose (150mg/kg) tested in
ethanol-induced gastric ulcer assay. The stomachs presented
hemorrhagic bands parallel to the long axis, and samples of
the stomachs were histopathologically analyzed. In contact
with the gastric mucosa, ethanol induces several histopatho-
logical alterations, such as hyperemia, hemorrhage, inflam-
matory cell infiltration, and edema [22]. In the HE staining,
such alterations are clearly recognized in the vehicle-treated
rats. In the group treated with B. holophylla, the gastric
mucosa appears to be more preserved, with less hemorrhage
and inflammatory infiltration. Ethanol ulcerates the gastric
mucosa through a direct necrotizing action, which impairs
the defensive factors of stomach, such as mucus production.
Ethanol also acts by dissolving the mucus barrier that covers
the gastric pits [23]. PAS staining colors the mucus barrier
in the stomach wall purple; this procedure demonstrated
that the mucus layer was preserved in B. holophylla-treated
rats. These results showed that a possible mechanism for
gastric mucosal protection offered by B. holophylla is a local
mechanism, reinforcing the resistance of the mucosal barrier
to the dissolving effect of ethanol, which creates a protective
coating that prevents direct contact between ethanol and the
epithelium.
Gastric ulcer induction by ethanol is the most prevalent
model for studying the pathogenesis of gastric injury and the
mechanisms of natural products that exhibit gastroprotec-
tion. Ethanol induces ulcers through a variety ofmechanisms,
including mucus depletion, mucosal excoriation, generation
of reactive oxygen species (ROS), and the release of inflam-
matory mediators. Cells of the stomach have several enzy-
matic systems that neutralize the harmful activity of ROS.
SOD catalyzes the dismutation of the superoxide anion (O
2
−)
into hydrogen peroxide (H
2
O
2
), which can be metabolized
by the activity of GPx and cooperating GR, accompanied by
the conversion of glutathione from its reduced form (GSH)
into its oxidized form, or by catalase [24]. However, ethanol
impairs the activity of SOD, catalase, GSH-Px, and GR and
lowers the level of GSH. The reduced antioxidant capacity
provoked by ethanol enhances lipid peroxidation, disturbing
membrane organization and leading to functional loss and
the modification of proteins and nitrogenous bases [25].
B. holophylla administration prior to ethanol enhanced the
activity of GSH-Px and GR and the level of GSH, suggesting
an antioxidant activity from B. holophylla that prevents the
oxidative effects of ethanol.
The administration of absolute ethanol triggers an inflam-
matory response, which leads to infiltration of inflammatory
cells (neutrophils and macrophages) at the site of gastric
injury formation [26]. Activated neutrophils release injurious
factors, including free radicals, proteolytic enzymes [27],
and MPO, which is a marker of neutrophil aggregation and
inflammation in the gastric mucosa [28]. MPO activity is
increased in the ulcerated stomach [29], as was seen in the
vehicle group, but decreased after treatment with B. holo-
phylla, providing further evidence for an anti-inflammatory
effect of B. holophylla. A decrease in MPO activity represents
a manifestation of the anti-inflammatory activity [30].
The inflammatory response developed by ethanol admin-
istration releases a number of proinflammatory cytokines
such as TNF-𝛼 and IL-6 [28]. TNF-𝛼 and IL-6 levels are
increased in ethanol-induced gastric ulcers, but the harmful
effect of these cytokines can be reversed by the administration
of natural products with anti-inflammatory activity. We
observed that the administration of ethanol leads to an
increase in gastric TNF-𝛼 and IL-6 levels, except in the BH-
treated group, remarkably, wherein the production of TNF-
𝛼 and IL-6 was inhibited. The elevated levels of the anti-
inflammatory cytokine IL-10 observed in the gastric tissue of
rats treated with B. holophylla can in part explain the decrease
in TNF-𝛼 production, as IL-10 inhibits the production of
TNF-𝛼 and suppresses the inflammatory response [31]. IL-10
is considered one of the most important anti-inflammatory
and immunosuppressive cytokines [32].
The scavenging of free radicals generated by lesive agents
and the recycling of antioxidants are also performed by
SH compounds [33]. SH compounds are responsible for
maintaining disulfide bridges, which in turn maintain the
protective barrier of mucus cohesive. The generation of
ethanol-induced gastric ulcers is associated with a decrease
in SH compounds [34], but the treatment with B. holophylla
was able to circumvent this process.
NO release from endothelial cells maintains gastric
mucosal integrity through interacting with neuropeptides,
decreasing lipid peroxidation, and modulation of hydrochlo-
ric acid and bicarbonate and mucus secretion [35]. Oral
administration of ethanol leads to an increase in NO pro-
duction, through induction of iNOS (inducible NO synthase)
expression [36]. NO increases cyclic guanosine monophos-
phate levels, leading to activation of the ATP sensitive
potassium channels (K+ATP), in a sequence of events that ends
in gastroprotection [37]. K+ATP channels mediate gastropro-
tection through the stimulation of gastric microcirculation
and the inhibition of neutrophil activation and subsequent
superoxide production [38]. Blocking NO production or
K+ATP channels reversed the gastroprotection offered by B.
holophylla. NO release and subsequent K+ATP channel acti-
vation are a pathway that contributes to the gastroprotective
mechanism of BH.
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Gyires et al. [39] concluded that peripheral 𝛼
2
-adreno-
ceptors are involved in gastric mucosal protection. Rats that
had the presynaptic𝛼
2
-adrenoceptors antagonized by yohim-
bine presented a decrease in the gastroprotection, even in
vehicle-treated or B. holophylla-treated groups, indicating
the participation of these receptors in the gastroprotection
offered by B. holophylla.
Antidiarrheal activity is an advantage for the antiulcer
agents because relaxation of circular muscles and flattening
of the folds in the stomach lead to an increase in the mucosal
area exposed to the necrotizing agent, decreasing the inci-
dence of ulcers [40]. Treatment of diarrhea can be performed
through decreasing peristalsis or decreasing secretion from
the intestinal mucosa [41]. B. holophylla offered antidiarrheal
activity through decreasing the incidence of watery stools,
possibly through reabsorption of water from the intestinal
content, because this effect was not accompanied by a
decrease in the gastrointestinal motility. Diarrheal disease
is the second leading cause of death in children under five
years old and is responsible for killing approximately 760,000
children every year [42].
The acute toxicity study of B. holophylla showed the non-
toxic nature of the extract at a dose of 5000mg/kg. During the
subsequent 14 days, the animals behaved normally, including
their consumption of water and food. The enzymes ALT and
AST are measured to indicate liver dysfunction; in this case,
their production increased [43]. In the same way, high levels
of urea and creatinine are indicators of nephrotoxicity [44].
Analysis of the rats’ serumdid not identify alterations in these
parameters, suggesting that oral treatment with B. holophylla
is safe when administered acutely.
In conclusion, the gastroprotective effect of B. holophylla
involves the maintenance of mucus barrier through the par-
ticipation of SH compounds, NO release, K+ATP channel acti-
vation, presynaptic 𝛼
2
receptor stimulation, and antioxidant
and anti-inflammatory activities, as well as an antidiarrheal
effect and the absence of acute toxicity.
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